Nestle Develops New Products for Weight-Loss Drug Users
Nestle is building high-protein foods and supplements for the millions now on GLP-1 drugs like Ozempic and Wegovy. Millions of people are on weight-loss drugs...
Tag : drug
Zydus Shares Slip Even as USFDA Clears Phase III Trial
Zydus Lifesciences shares slipped 2% on the NSE on Thursday, even after the company cleared a big regulatory hurdle for a new drug trial. The...
Neuland Laboratories Shares Gain Over 8% After USFDA Approval for BMS Schizophrenia Drug
Shares of Neuland Laboratories Ltd. rallied over 8% to reach a day’s high of Rs 13,630.00 on 27th September, following the USFDA approval of Bristol...
Sun Pharmaceutical Shares Slump 1% as USFDA Issues a Warning Letter
Shares of Sun Pharmaceutical Industries Ltd were trading in the red and 1.68% lower on 3 July after the US Food and Drug Administration (USFDA)...
Dr. Reddy Is Up With Exiting Non-core Businesses
India’s second-largest drugmaker by revenue, Dr. Reddy will sell its U.S. and select territory rights for Zembrace and Tosymra (used for treating migraine), which were...
Lupin Recalling Over 12,000 Cartons of Birth Control Drug
As per a report of the U.S health regulator, drug firm Lupin Ltd. is recalling over 12,000 cartons of Fayosim Tablets which is birth control...
Cadila gets USFDA approval to market drug for prostate condition
Zydus Cadila has received final approval from the US health regulator to market Dutasteride and Tamsulosin Hydrochloride capsules. It is used to treat symptoms of Benign...
Orchid Pharma receives approval for schizophrenia drug from USFDA
Orchid Pharma receives approval for Aripiprazole Orally-Disintegrating tablets from the US health regulator. The company in a filing to BSE stated it, “has received ANDA (abbreviated...
Cadila receives USFDA approval for drug that treats schizophrenia
Cadila Healthcare’s subsidiary, has received approval from the US health regulator for Clozapine tablets, which is used to treat schizophrenia. In a filing the company stated,...
Cadila gets USFDA approval for blood pressure treatment drug
Zydus Cadila has received final approval to market Candesartan Cilexetil and Hydrochlorothiazide tablets formulations, from the US health regulator. It is used for treating high blood...